Skip to main content
OpenTrials

Clinical trial condition

Kidney Diseases

Explore clinical trials studying Kidney Diseases. Study availability and eligibility vary by location and protocol.

8,795 public trials 1,411 recruiting studies
Refine in advanced search Browse all conditions

Kidney Diseases trial results

Recruiting

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

NCT07107945

Conditions
Chronic Disease, Chronic Kidney Disease, Disease Attributes, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
View all 102 locations
View Trial Details
Recruiting

Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003

NCT06714006

Conditions
Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease (ADPKD), Ciliopathies, +12 more
Locations
  • South Coast Renal, Brockway House, Level 1, Suite 8, 82-86 Queen Street, Southport, Gold Coast, Australia
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • Liverpool Hospital, Clinic G-Reception 133, Level 1, Clinical Building, Burnside Drive Liverpool, New South Wales, Australia
  • Scientia Clinical Research Randwick, New South Wales, Australia
View Trial Details
Recruiting

A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis

NCT07598396

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +13 more
Locations
  • Clnica SER da Bahia Salvador, Estado de Bahia, Brazil
  • L2IP ?Instituto de Pesquisas Clínicas Ltda. Brasília, Federal District, Brazil
  • IPC MT Instituto de Pesquisas Clinicas do Mato Grosso Cuiab, Mato Grosso, Brazil
  • Complexo Hospitalar de Niteroi Niterói, Rio de Janeiro, Brazil
View all 17 locations
View Trial Details
Recruiting

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

NCT07489495

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0102) Marietta, Georgia, United States
  • The West Clinic, P.C. ( Site 0115) Germantown, Tennessee, United States
  • Centro Oncologico Korben ( Site 0254) CABA, Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires ( Site 0253) Ciudad de Buenos Aires, Buenos Aires, Argentina
View all 66 locations
View Trial Details
Recruiting

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

NCT06989359

Conditions
Autoimmune Diseases, C3G, Complement-mediated Kidney Disease, +13 more
Locations
  • ADARx Clinical Site Doral, Florida, United States
  • ADARx Clinical Site Miami, Florida, United States
  • ADARx Clinical Site Pembroke Pines, Florida, United States
  • ADARx Clinical Site Iowa City, Iowa, United States
View all 34 locations
View Trial Details
Recruiting

Pivotal Study of the Velocity™ pAVF System

NCT07153939

Conditions
Arteriovenous Fistula, Arteriovenous Malformations, Cardiovascular Abnormalities, +24 more
Locations
  • Trinity Research Group Dothan, Alabama, United States
  • West Coast Kidney Institute Concord Concord, California, United States
  • Apex Research Riverside, California, United States
  • Vascular and Embolization Specialists Cocoa, Florida, United States
View Trial Details
Recruiting

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

NCT07227402

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Alaska Oncology and Hematology ( Site 0133) Anchorage, Alaska, United States
  • Providence Medical Foundation ( Site 0141) Fullerton, California, United States
  • Cedars-Sinai Medical Center ( Site 0112) Los Angeles, California, United States
  • New England Cancer Specialists ( Site 0132) Westbrook, Maine, United States
View all 124 locations
View Trial Details

Related conditions